These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21330352)
41. Low HLA-DR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro. Yang HM; Yu Y; Chai JK; Hu S; Sheng ZY; Yao YM Burns; 2008 Dec; 34(8):1158-62. PubMed ID: 18538934 [TBL] [Abstract][Full Text] [Related]
42. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children. Sikora JP; Kuzański W; Andrzejewska E Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968 [TBL] [Abstract][Full Text] [Related]
43. The response of lymphocyte beta-adrenergic receptors to chronic propranolol treatment in depressed patients, schizophrenic patients, and normal controls. Zohar J; Bannet J; Drummer D; Fisch R; Epstein RP; Belmaker RH Biol Psychiatry; 1983 May; 18(5):553-60. PubMed ID: 6305430 [TBL] [Abstract][Full Text] [Related]
44. Long-term propranolol use in severely burned pediatric patients: a randomized controlled study. Herndon DN; Rodriguez NA; Diaz EC; Hegde S; Jennings K; Mlcak RP; Suri JS; Lee JO; Williams FN; Meyer W; Suman OE; Barrow RE; Jeschke MG; Finnerty CC Ann Surg; 2012 Sep; 256(3):402-11. PubMed ID: 22895351 [TBL] [Abstract][Full Text] [Related]
45. Interleukin-1 from baboon peripheral blood monocytes: altered response to endotoxin (lipopolysaccharide) and Staphylococcus aureus stimulation compared with human monocytes. von Bülow GU; Puren AJ; Savage N Eur J Cell Biol; 1992 Dec; 59(2):458-63. PubMed ID: 1493811 [TBL] [Abstract][Full Text] [Related]
46. [Epidemiologic studies of the microbial colonization of severely burned patients]. Winkler M; Erbs G; Müller FE; König W Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Jun; 184(3-4):304-20. PubMed ID: 3116791 [TBL] [Abstract][Full Text] [Related]
47. Systematic review of the effect of propanolol on hypermetabolism in burn injuries. Núñez-Villaveirán T; Sánchez M; Millán P; García-de-Lorenzo A Med Intensiva; 2015 Mar; 39(2):101-13. PubMed ID: 25305241 [TBL] [Abstract][Full Text] [Related]
48. Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome. Peruhype-Magalhães V; Martins-Filho OA; Prata A; Silva Lde A; Rabello A; Teixeira-Carvalho A; Figueiredo RM; Guimarães-Carvalho SF; Ferrari TC; Correa-Oliveira R Scand J Immunol; 2005 Nov; 62(5):487-95. PubMed ID: 16305646 [TBL] [Abstract][Full Text] [Related]
50. IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression. Hermann P; Rubio M; Nakajima T; Delespesse G; Sarfati M J Immunol; 1998 Aug; 161(4):2011-8. PubMed ID: 9712074 [TBL] [Abstract][Full Text] [Related]
51. Regulation of lipolysis in severely burned children. Wolfe RR; Herndon DN; Peters EJ; Jahoor F; Desai MH; Holland OB Ann Surg; 1987 Aug; 206(2):214-21. PubMed ID: 3606248 [TBL] [Abstract][Full Text] [Related]
52. Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children. Herndon DN; Voigt CD; Capek KD; Wurzer P; Guillory A; Kline A; Andersen CR; Klein GL; Tompkins RG; Suman OE; Finnerty CC; Meyer WJ; Sousse LE Ann Surg; 2016 Sep; 264(3):421-8. PubMed ID: 27433905 [TBL] [Abstract][Full Text] [Related]
53. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Herndon DN; Barrow RE; Rutan TC; Minifee P; Jahoor F; Wolfe RR Ann Surg; 1988 Oct; 208(4):484-92. PubMed ID: 3052328 [TBL] [Abstract][Full Text] [Related]
54. Propranolol Normalizes Metabolomic Signatures Thereby Improving Outcomes After Burn. Rehou S; de Brito Monteiro L; Auger C; Knuth CM; Abdullahi A; Stanojcic M; Jeschke MG Ann Surg; 2023 Oct; 278(4):519-529. PubMed ID: 37389480 [TBL] [Abstract][Full Text] [Related]
55. A survey of the use of propranolol in burn centers: Who, what, when, why. LeCompte MT; Rae L; Kahn SA Burns; 2017 Feb; 43(1):121-126. PubMed ID: 27575676 [TBL] [Abstract][Full Text] [Related]
56. Effects of Propranolol in Accelerating Wound Healing and Attenuation of Hypermetabolism in Adult Burn Patients. Cheema SA; Ahmed UT; Nasir H; Dogar SR; Mustafa Z J Coll Physicians Surg Pak; 2020 Jan; 30(1):46-50. PubMed ID: 31931932 [TBL] [Abstract][Full Text] [Related]
57. Myelo-erythroid commitment after burn injury is under β-adrenergic control via MafB regulation. Hasan S; Johnson NB; Mosier MJ; Shankar R; Conrad P; Szilagyi A; Gamelli RL; Muthumalaiappan K Am J Physiol Cell Physiol; 2017 Mar; 312(3):C286-C301. PubMed ID: 28031160 [TBL] [Abstract][Full Text] [Related]
58. Prolonged use of propranolol safely decreases cardiac work in burned children. Baron PW; Barrow RE; Pierre EJ; Herndon DN J Burn Care Rehabil; 1997; 18(3):223-7. PubMed ID: 9169945 [TBL] [Abstract][Full Text] [Related]
59. Cold stress response in patients with severe burns after beta-blockade. Honeycutt D; Barrow R; Herndon D J Burn Care Rehabil; 1992; 13(2 Pt 1):181-6. PubMed ID: 1350283 [TBL] [Abstract][Full Text] [Related]
60. The Safety and Efficacy of Propranolol in Reducing the Hypermetabolic Response in the Pediatric Burn Population. Ojeda S; Blumenthal E; Stevens P; Andersen CR; Robles L; Herndon DN; Meyer WJ J Burn Care Res; 2018 Oct; 39(6):963-969. PubMed ID: 29757441 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]